CI
Capital International Portfolio holdings
AUM
$2.61B
This Quarter Return
+6.83%
1 Year Return
+36.08%
3 Year Return
+158.9%
5 Year Return
+280.54%
10 Year Return
+783.6%
AUM
$1.64B
AUM Growth
+$1.64B
(+2%)
Cap. Flow
+$10.7M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
28.37%
Holding
188
New
18
Increased
37
Reduced
69
Closed
10
Top Buys
| 1 |
Incyte
INCY
|
$39.9M |
| 2 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$19.9M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$18.8M |
| 4 |
Digital Realty Trust
DLR
|
$17.2M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$15.5M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$53.8M |
| 2 |
AbbVie
ABBV
|
$17.3M |
| 3 |
VeriSign
VRSN
|
$16.3M |
| 4 |
BRCM
BROADCOM CORP CL-A
BRCM
|
$11.7M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$10.9M |
Sector Composition
| 1 | Healthcare | 16.14% |
| 2 | Financials | 15.52% |
| 3 | Technology | 11.49% |
| 4 | Energy | 11.08% |
| 5 | Consumer Discretionary | 7.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Goldman Sachs
GS
$226B
| $71.2M | 4.34% | 367,200 +10,100 | +3% | +$1.96M |
|
2
Chevron
CVX
$324B
| $56.3M | 3.43% | 501,929 -16,400 | -3% | -$1.84M |
|
|
3
Gilead Sciences
GILD
$140B
| $54.5M | 3.32% | 578,300 -570,800 | -50% | -$53.8M |
|
4
Bristol-Myers Squibb
BMY
$96B
| $45.4M | 2.77% | 769,800 -70,300 | -8% | -$4.15M |
|
5
Microsoft
MSFT
$3.77T
| $41.5M | 2.53% | 893,800 +165,900 | +23% | +$7.71M |
|
|
6
Alphabet (Google) Class C
GOOG
$2.58T
| $41.3M | 2.52% | 78,128 +35,647 | +84% | +$18.8M |
|
7
CME Group
CME
$96B
| $40.9M | 2.5% | 461,700 +15,600 | +3% | +$1.38M |
|
|
8
Incyte
INCY
$16.5B
| $39.9M | 2.44% | +546,400 | New | +$39.9M |
|
9
Newell Brands
NWL
$2.48B
| $37.4M | 2.28% | 982,750 +253,100 | +35% | +$9.64M |
|
10
Apple
AAPL
$3.45T
| $36.9M | 2.25% | 334,559 -53,200 | -14% | -$5.87M |
|
11
Wells Fargo
WFC
$263B
| $34M | 2.07% | 619,600 +200,000 | +48% | +$11M |
|
12
ConocoPhillips
COP
$124B
| $31.6M | 1.93% | 458,100 +65,700 | +17% | +$4.54M |
|
13
Danaher
DHR
$147B
| $31.2M | 1.9% | 364,400 -62,400 | -15% | -$5.35M |
|
14
Visa
V
$683B
| $30.4M | 1.85% | 115,870 -5,100 | -4% | -$1.34M |
|
15
Eaton
ETN
$136B
| $29.7M | 1.81% | 437,600 -36,600 | -8% | -$2.49M |
|
16
Procter & Gamble
PG
$368B
| $28.3M | 1.73% | 310,900 -17,100 | -5% | -$1.56M |
|
17
American Tower
AMT
$95.5B
| $27M | 1.65% | 273,300 -37,500 | -12% | -$3.71M |
|
18
Royal Caribbean
RCL
$98.7B
| $26.7M | 1.62% | 323,300 -96,100 | -23% | -$7.92M |
|
19
Marsh & McLennan
MMC
$101B
| $26.3M | 1.6% | 458,600 -67,300 | -13% | -$3.85M |
|
20
Vale
VALE
$43.9B
| $25.6M | 1.56% | 3,129,400 +64,400 | +2% | +$527K |
|
21
Whirlpool
WHR
$5.21B
| $23.8M | 1.45% | 122,700 +31,300 | +34% | +$6.06M |
|
22
Schlumberger
SLB
$55B
| $23.1M | 1.41% | 270,396 -16,400 | -6% | -$1.4M |
|
23
Starbucks
SBUX
$100B
| $23.1M | 1.41% | 281,349 -4,500 | -2% | -$369K |
|
24
Cenovus Energy
CVE
$29.9B
| $21.3M | 1.3% | 1,030,400 -73,900 | -7% | -$1.53M |
|
25
Merck
MRK
$210B
| $21.2M | 1.29% | 373,300 +187,300 | +101% | +$10.6M |
|